单位:[a]Laboratory of Molecular Autoimmune Disease, Brigham and Women's Hospital, Boston, MA, United States[b]Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States[c]Department of Nephrology and Rheumatology, Johannes-Gutenberg University Mainz, Mainz, Germany[d]Harvard Stem Cell Institute, Cambridge, MA, United States[e]Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, United States[f]Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院
第一作者单位:[a]Laboratory of Molecular Autoimmune Disease, Brigham and Women's Hospital, Boston, MA, United States[b]Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
通讯作者:
通讯机构:[a]Laboratory of Molecular Autoimmune Disease, Brigham and Women's Hospital, Boston, MA, United States[b]Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
推荐引用方式(GB/T 7714):
Baek J.-H,Zeng R,Weinmann-Menke J,et al.IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease[J].Journal of Clinical Investigation.2015,125(8):doi:10.1172/JCI81166.
APA:
Baek, J.-H,Zeng, R,Weinmann-Menke, J,Valerius, M.T,Wada, Y...&Kelley, V.R.(2015).IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.Journal of Clinical Investigation,125,(8)
MLA:
Baek, J.-H,et al."IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease".Journal of Clinical Investigation 125..8(2015)